Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Unigreg Worldwide Limited, operating as UWL Pharma, is a specialty pharmaceutical and nutraceutical company focused on the development and distribution of high-quality health products in China and international markets. The company is best known for its flagship brand, Forceval, a comprehensive range of multivitamins and minerals that has led the maternal health nutrition category in China for over 15 years. Headquartered in the UK with significant operations in Hong Kong and Guangzhou, Unigreg specializes in bridging international healthcare products with the Chinese market through its expertise in registration, marketing, and distribution. Its portfolio includes specialized formulations for pregnancy, pediatric care, and general wellness, distributed through hospitals, pharmacies, and e-commerce channels. Originally established as a joint venture with Alliance Pharma, the company became independent in 2018 and continues to expand its presence in the global specialty healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Unigreg.